New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 16, 2014
07:08 EDTTGTXTG Therapeutics price target raised to $18 from $12 at Ladenburg
Ladenburg raised its price target for TG Therapeutics shares to $18 citing the positive initial TG-1101 plus ibrutinib combination Phase II trial data. The firm reiterates a Buy rating on the stock.
News For TGTX From The Last 14 Days
Check below for free stories on TGTX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 15, 2014
07:31 EDTTGTXTG Therapeutics commences clinical study that combines TG-1101, TGR-1202
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use